Clinical Trials Directory

Trials / Unknown

UnknownNCT04154358

Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Augusta University · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Accepted

Summary

Transgender men are individuals born genetically female that have a gender identity that is incongruent with their biological sex. For those who have begun or completed transition, they may present as males but still have a uterus and cervix. Thus far, no distinction has been made between routine cervical cancer screening guidelines in non-transgender women and those for transgender men, despite wide variations in sexual practices, including lifelong vaginal abstinence. The purpose of this study is to offer transgender men seen at clinic visits self-collected HPV testing to evaluate for improved cervical cancer screening rates, as well as a survey to further investigate sexual practices, rates of appropriate screening prior to being offered self-collection, and barriers to obtaining appropriate care.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHPV testingwill perform HPV testing with self-collected specimen

Timeline

Start date
2020-05-01
Primary completion
2020-06-30
Completion
2020-12-31
First posted
2019-11-06
Last updated
2020-03-23

Source: ClinicalTrials.gov record NCT04154358. Inclusion in this directory is not an endorsement.